AMERIPRISE FINANCIAL INC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 45 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$12,259,000
+18.2%
5,000,0000.0%0.00%0.0%
Q3 2020$10,368,000
-9.6%
5,000,0000.0%0.00%
-20.0%
Q2 2020$11,475,000
+51.2%
5,000,0000.0%0.01%
+25.0%
Q1 2020$7,589,000
-22.0%
5,000,0000.0%0.00%0.0%
Q4 2019$9,725,000
+130.0%
5,000,000
+56.2%
0.00%
+100.0%
Q3 2019$4,228,000
-62.0%
3,200,000
-36.0%
0.00%
-60.0%
Q2 2019$11,130,000
+54.2%
5,000,000
+25.0%
0.01%
+66.7%
Q1 2019$7,218,0004,000,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$148,264,0002.95%
DeepCurrents Investment Group LLC 45,997,000$76,672,0002.94%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$64,158,0001.47%
WOLVERINE ASSET MANAGEMENT LLC 71,012,000$118,356,0001.28%
Opti Capital Management, LP 3,000,000$5,013,0000.46%
MIZUHO SECURITIES USA LLC 1,663,000$2,766,0000.38%
Verition Fund Management LLC 25,954,000$21,680,6590.24%
Aequim Alternative Investments LP 5,000,000$8,345,0000.24%
PALISADE CAPITAL MANAGEMENT, LP 3,831,000$6,522,0000.18%
LORD, ABBETT & CO. LLC 23,424,000$39,095,0000.14%
View complete list of SAREPTA THERAPEUTICS INC shareholders